Deen Alsalman
StoryYearsZeldaSmashMarioMinecraftCancersBrain TumoursContactLinks

Share this page

Spinal Cord Glioma

Tumors that occur in the spinal cord.

Location

Spinal cord

Histological Classification

Glioma


Details

Origin: Glial cells

Grade: I-III

Severity: Medium

Molecular Marker: IDH

Age Range: 5-15 years

Life Expectancy: 5-10 years

Lifespan Impact

Summary

Spinal Cord Glioma is a type of glioma that occurs in the spinal cord. Gliomas are tumors that originate from glial cells, which are supportive cells in the nervous system. While gliomas are more commonly found in the brain, spinal cord gliomas are less frequent but can have significant effects due to their location.

Symptoms

The symptoms of spinal cord gliomas can vary depending on the tumor's size and location. Common symptoms include:

  • Pain: Back pain is often the first symptom, which may radiate to the limbs or other parts of the body.
  • Weakness: Muscle weakness or decreased motor control in the limbs is common.
  • Sensory Changes: Numbness, tingling, or loss of sensation, particularly in the extremities.
  • Coordination Problems: Difficulty walking or maintaining balance.
  • Bladder or Bowel Dysfunction: Difficulty controlling urination or bowel movements.
  • Scoliosis: In children, spinal cord gliomas may cause or exacerbate scoliosis.

Conventional Treatments

  1. Surgery:

    • Purpose: Primary approach to remove as much of the tumor as possible.
    • Limitations: Due to the delicate nature of the spinal cord, complete removal is often challenging.
    • Modern Techniques: Use of intraoperative MRI and neuro-navigation to improve precision.
    • Side Effects: Risk of neurological damage, infection, and spinal instability.
  2. Radiation Therapy:

    • Purpose: Used post-surgery to destroy remaining tumor cells or as a primary treatment if surgery is not feasible.
    • Modern Techniques: Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic Radiosurgery (SRS) allow for targeted delivery.
    • Side Effects: Fatigue, skin irritation, nausea, and potential long-term neurological damage.
  3. Chemotherapy:

    • Purpose: Less commonly used for spinal cord gliomas, but may be employed in specific cases.
    • Drugs Used: Temozolomide is often used in the treatment of gliomas.
    • Side Effects: Nausea, vomiting, hair loss, and increased risk of infection.

Experimental Treatments

  1. Targeted Therapy:

    • Description: Focuses on specific molecular targets associated with tumor growth.
    • Examples: Drugs like Bevacizumab (Avastin) which inhibit vascular endothelial growth factor (VEGF).
    • Side Effects: Hypertension, bleeding, thromboembolic events.
  2. Immunotherapy:

    • Description: Uses the body's immune system to fight cancer cells.
    • Current Research: Trials investigating checkpoint inhibitors and CAR-T cell therapy.
    • Side Effects: Autoimmune reactions, flu-like symptoms, and fatigue.
  3. Gene Therapy:

    • Description: Involves altering the genetic material within cells to fight cancer.
    • Status: Still largely experimental with ongoing clinical trials.
    • Side Effects: Potential for unintended genetic alterations and immune responses.
  4. Clinical Trials:

    • Information: Patients may have access to cutting-edge treatments through clinical trials.
    • Resources: ClinicalTrials.gov is a resource for finding trials.

Side Effects

The side effects of treatments for spinal cord gliomas vary with the type of treatment and can range from mild to severe. It is crucial for patients to discuss potential side effects with their healthcare providers to make informed decisions about their treatment options.

Timeline of Modern Treatments

  • Surgery: Advancements in surgical techniques and equipment have improved outcomes, particularly in the past two decades.
  • Radiation Therapy: Techniques like IMRT and SRS have become more widely available since the early 2000s.
  • Chemotherapy: Temozolomide was approved for use in gliomas in the early 2000s.
  • Experimental Therapies: Most are still in clinical trial phases, but significant advances have been made in the last decade, particularly in immunotherapy and targeted therapy.

Conclusion

Spinal cord gliomas present unique challenges due to their location and the critical functions of the spinal cord. While conventional treatments have been the mainstay, ongoing research into experimental therapies holds promise for more effective management with fewer side effects. Patients should consider enrolling in clinical trials to access the latest treatment options.